Table 3.
Seizures etiology × semiology
| Clonic | Tonic | Myoclonic | Automatisms | Spasms | Sequential | Autonomic | |
|---|---|---|---|---|---|---|---|
| Etiology/seizure classification, n (%) | |||||||
| HIE (n = 6) | 1 (16.7%) | 0 (0.0%) | 0 (0.0%) | 1 (16.7%) | 0 (0.0%) | 1 (16.7%) | 3 (50.0%) |
| Cortical malformations (n = 3) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (66.7%) | 1 (33.3%) |
| CNS infection (n = 4) | 3 (75.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (25.0%) | 0 (0.0%) |
| Metabolic disorders | |||||||
| Electrolyte imbalance (n = 3) | 1 (33.3%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (33.3%) | 1 (33.3%) |
| Inborn errors of metabolism (n = 3) | 0 (0.0%) | 0 (0.0%) | 3 (100%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| vitamin‐related disorders (n = 11) | 2 (18.2%) | 0 (0.0%) | 2 (18.2%) | 0 (0.0%) | 0 (0.0%) | 7 (63.6%) | 0 (0.0%) |
| Withdrawal (n = 2) | 1 (50.0%) | 0 (0.0%) | 1 (50.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Genetic disorders | |||||||
| Channelopathy (n = 67) | 5 (7.5%) | 26 (38.8%) | 3 (4.5%) | 0 (0.0%) | 0 (0.0%) | 33 (49.3%) | 0 (0.0%) |
| Chromosomal disorder (n = 3) | 1 (33.3%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (33.3%) | 1 (33.3%) |
| Other gene disorders (n = 7) | 2 (28.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (28.6%) | 3 (42.9%) | 0 (0.0%) |
| Vascular disorders | |||||||
| Stroke (n = 25) | 18 (72.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 5 (20.0%) | 2 (8.0%) |
| Hemorrhage (n = 8) | 2 (25.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (25.0%) | 4 (50.0%) |
| Unknown Undetermined/(n = 9) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (11.1%) | 6 (66.7%) | 2 (22.2%) |
CNS, central nervous system.